Skip to main content
. 2009 Oct 6;3(6):479–484. doi: 10.1007/s11832-009-0206-5

Table 1.

Clinical findings of the patients studied

Case Age (years) Sex Duration (days) Initial diagnosis Temp (°C) WBC (/ml) ESR (mm/h) CRP (mg/l) Organism Surgery Antibiotics
1 6.6 F 10 Septic arthr. hip 38.1 15.2 70 3.5 S. aureus N Cloxacillin
2 10.8 M 5 Septic arthr. hip 38.7 16.8 32 1.1 S. aureus N Cloxacillin
3 12.4 M 5 Trochanteric pain 38.5 13.4 78 18 Neg Y Cloxacillin
4 5.2 F 7 Invasive g/e 39.3 18.7 32 9.8 B. fragilis Y Clindamycin
5 15.3 F 15 Sacroiliitis 39 12.7 110 6.2 S. aureus Y Tobramycin
6 5.4 F 8 Sacroiliitis 39.8 14 65 25 S. aureus Y Amoxicillin
7 16.0 M 5 Crohn disease 37.8 24.5 58 6.5 Neg Y Meropenem
8 12.4 M 10 Septic arthr. hip 37.8 20.8 45 1.3 Neg N Cefotaxime
9 8.1 F 2 Septic arthr. hip 39.3 14.6 97 17 Neg N Cloxacillin + cefotaxime
10 2.9 M 8 Sacroiliitis 38 14.06 52 12.6 Neg N Cefotaxime
11 6.3 F 12 Appendicitis 39 17 35 27.6 Neg N Cefotaxime + clindamycin

F female, M male, g/e gastroenteritis, WBC white blood cell count, ESR erythrocyte sedimentation rate, CRP C-reactive protein, neg negative culture